← Latest news 
From facilitator to regulator Rajeev Raghuvanshi tackles pharma quality crisis after Gambia deaths
Business
Published on 24 April 2026
He inherits a reputation collapse after 70 children died
After 70 children died in Gambia in 2022 linked to contaminated cough syrups, India’s pharma sector and its top regulator faced a credibility crisis. Rajeev Raghuvanshi, appointed Drug Controller General of India, is now pushing a transformation aimed at closing regulatory gaps and tightening product quality. The big question: can enforcement finally keep pace?
- Gambia deaths triggered a major reputation blow for pharma and regulators
- Rajeev Raghuvanshi has taken charge as Drug Controller General of India
- A transformational shift is underway to close quality and oversight gaps
- The central test is whether higher standards translate into action
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times